# MRAM 2026 and NITI Aayog Data on Equipment Maintenance Gaps: A Brief for US Practices

> Pharmabiz reports that MRAM 2026 speakers urged India's healthcare and pharma sectors to move from breakdown repairs to predictive maintenance, citing NITI Aayog findings on equipment and record-keeping gaps.

iPMS Practice Desk · 2026-10-09 · https://blog.myipms.app/mram-2026-and-niti-aayog-data-on-equipment-maintenance-gaps-a-brief-for-us-pract

Pharmabiz reported from Mumbai on October 8, 2026, that industry leaders at MRAM 2026 called on India's healthcare and pharmaceutical sectors to shift from reactive, breakdown-based maintenance toward predictive, AI-enabled and reliability-centred asset management [1]. The story presents equipment maintenance as both a productivity issue and a patient-care issue [1]. It draws on NITI Aayog assessments that found significant gaps in the inspection, calibration and maintenance of biomedical equipment [1].

## What the story reports

The article contrasts reactive maintenance, which responds to breakdowns, with predictive approaches that aim to identify potential failures before they disrupt critical operations [1].

The figures in the piece come from different kinds of source and carry different weight [1]:

- NITI Aayog noted that various studies have found 40–60% of biomedical equipment can be non-operational because of inadequate maintenance services; the article does not name those studies [1].
- In a separate assessment of 100 hospital emergency departments, only 66 had records of periodic inspection and calibration of biomedical equipment, and 67 maintained an equipment inventory and log books [1].
- Research on Indian pharmaceutical manufacturing identified poor maintenance and breakdowns as major contributors to productivity losses, and found that the failure of a critical machine could halt an entire API production plant [1].
- An industry estimate puts one hour of unplanned downtime in a pharma plant at approximately Rs. 50,000 to Rs. 5 lakh, depending on the facility, with further exposure from lost production, rejected batches and compliance risks [1].
- NITI Aayog's "AI for Viksit Bharat" report identifies predictive maintenance as an important AI application in manufacturing and estimates that AI-led productivity and efficiency gains could generate $85–100 billion in additional value for India's manufacturing sector by 2035 [1].

## Why it matters to US outpatient practices

The data describe Indian hospitals and manufacturing plants, and the article draws no conclusions about other countries [1]. Its broader framing, however, is that equipment reliability bears on care delivery, and it reports NITI Aayog's view that better equipment management and maintenance are essential for improving healthcare delivery [1].

The emergency department figures concern documentation rather than equipment failure: whether facilities kept periodic inspection and calibration records, and whether they maintained an equipment inventory and log books [1].

Anitha Raghunath, quoted without a stated title, said that "Reliable medical equipment can directly support continuity of patient care" [1]. She argued that in healthcare and pharmaceuticals the move to reliability-centred maintenance matters for more than reducing maintenance costs [1].

## What to watch next

Several points in the story remain open [1]:

- **Measured outcomes.** The monetary figures are a report's projection of AI-led gains and an industry estimate of downtime cost; the article reports no results from evaluated predictive maintenance programmes [1].
- **Speaker claims.** Martin Robinson, identified as founder and CEO of IRISS Group, USA, listed benefits including greater equipment availability, longer asset life, lower operating costs and less waste; the article presents no data supporting those statements [1].
- **Policy follow-through.** The story reports NITI Aayog's emphasis on better equipment management but describes no implementation plan, timeline or requirement for facilities [1].

## Limitations

This take rests on a single trade-press article that reports NITI Aayog findings at second hand [1]. The 40–60% range is attributed to unnamed studies [1]. The emergency department assessment is described without dates, sampling method or location details [1]. The downtime cost is an industry estimate rather than a measured figure [1]. The statements from Anitha Raghunath and Martin Robinson are speakers' views rather than data [1].

## References

1. pharmabiz.com. Poor maintenance puts healthcare equipment and pharma productivity at risk: MRAM 2026. Accessed October 8, 2026. https://www.pharmabiz.com/NewsDetails.aspx?aid=191130&sid=2